Genmab Announces U.S. FDA Approval of DARZALEX (daratumumab) Split Dosing Regimen
- DARZALEX split dosing regimen approved by U.S. FDA
- Provides healthcare professionals with option to split first DARZALEX infusion over two consecutive days
- Approval supported by data from EQUULEUS (MMY1001) clinical trial
Attachment